Oil Red O staining showed that the accumulation of lipid drops was reduced after oe-Foxa2 treatment (Fig. 2C), suggesting that Foxa2 could suppress hepatic steatosis in NAFLD mice. Here, FOXA2 is linked to metabolic dysfunction-associated steatotic liver disease.